Finding Inspiration in Every Turn
Pakistan presents a very precarious scenario vis-à-vis heart attacks, heart failures and other cardiac ailments as these are the leading cause of deaths in our country. Every hour, 46 people die in Pakistan due to cardiac ailments. While there is an ever-growing national demand for cardiovascular devices and implants, Pakistan is completely dependent on imported cardiac devices. Because of their exorbitant costs, the imported devices are accessible by only 20% of the diseased population, rendering the remaining 80% deprived of treatment that can improve their health and life expectancy.
Instituted, under special directives of the Prime Minister’s Office and Supreme Court of Pakistan, at National University of Sciences & Technology (NUST), Islamabad, N-ovative Health Technologies (NHT) Pvt Ltd is dedicated to create healthcare solutions that meet the immediate demand of the country, with a special emphasis on saving precious foreign exchange, amounting to PKR 8.5 billion, on cardiac stent and catheter imports every year, and on the generation of foreign exchange through exports.
NHT is a state-of-the-art medical device manufacturing facility actively working in research and development of healthcare technologies as well as mass production of life-saving medical devices and implants such as Bare Metal stents, Drug-Eluting Stents, Angioplasty Balloon Catheters, Diagnostic Angiographic Catheters, ventilators etc, to be made available at a fraction of prices of their imported versions.
Sponsored by the Ministry of Sciences & Technology (MoST) with the mandate of indigenously manufacturing cost-effective high-quality medical devices, the facility is established as a public sector company with the Securities Exchange & Commission of Pakistan (SECP). NHT is ISO 13485:2016 certified from European Commission Notified Body and is approved by Drug Regulatory Authority of Pakistan (DRAP).
“Don’t limit yourself. Many people limit themselves to what they think they can do. You can go as far as your mind lets you. What you believe, remember, you can achieve.”
Dr Murtaza Najabat Ali
Member of the Board
To set national and regional trends of technology innovation and self-sufficiency by indigenous production of medical devices, redefining healthcare in Pakistan and bringing solutions within the reach of common man.
To indigenously develop high-quality medical devices for local and international markets, that provide customer satisfaction in safety, quality and affordability, while complying with applicable international standards and regulatory requirements
History of Department
In 2006 Dr. Murtaza Najabat Ali while working in UK University developed a low-cost stent and inform President of Pakistan about its significant potential benefits for the deprived segments of the society. In 2007 he joined NESCOM on invitation of Chairman (Dr. Samar Mubarakmand) and established a pilot production plant where the initial R&D was carried out and Bare Metal Stent (stainless steel) was developed in collaboration with AFIC. In 2009 Dr. Murtaza Najabat Ali left for UK because NESCOM did not intend to take the established pilot-scale facility to the next level (i.e., commercial scale production). In 2013 Dr. Murtaza returned from UK & joined NUST to establish Bio medical engineering dept. at SMME where extensive research on medical devices technology was initiated. In 2014 effort was initiated with NESCOM for the transfer of stent production technology at NUST. In 2015 MoST approved Rs. 33 Million PC-1 for the establishment of facility to manufacture Angioplastry Balloon (PTCA) Catheters at NUST In 2016, the entire stent production technology worth RS. 55 Million located in NESCOM was transferred to NUST through MoST.In 2017, P.M Office and Supreme Court of Pakistan took notice of implanting substandard stents in patients in Punjab and gave Rector NUST and Dr. Murtaza a mandate to submit a new PC-1 related to the development of purpose-built Medical Devices Development Center (MDDC) at NUST.
In 2017, a PC-1 of worth Rs. 331.12 Million was approved by MoST . In 2017, core production team obtained training from the industrial partner in Germany. In 2017, the entire Production Technology (production and testing machines) were procured from industrial partners in Germany. In 2019 all the prerequisites pertaining to the international and national certification/lisencing of both production facility and products were successfully completed. In 2020, a state-of-the-art stent manufacturing facility was established and PC-IV against Rs. 331.12M was submitted to MoST.
During the completion of PC-1 related to the establishment of MDDC Project, Federal Government gave the following directives:
Take this project to the regular side (i.e. regular Operational Budget should be provided) and a Special Purpose Vehicle (SPV) in the form of Public Sector Company mode should be established for the commercialization of the MDDC Products.
Upscaling of production capacity in future with the help of Private Sector Partnership.
After the successful completion of PC-1, SPV in the form of Public Sector Company Mode as per the directives of Federal Government (N-ovative Health Technologies- NHT) was incorporated in July 2020 with Security Exchange Commission of Pakistan (SECP)
On 16th October 2020, Prime Minister Imran Khan inaugurated the N-ovative Health Technology Facility at the National University of Science and Technology (NUST).
Board of Directors
Col Tahir Bashir Malik (R)
Dr Murtaza Najabat Ali
Col Mumtaz Mirza (R)